• Publications
  • Influence
Adherence to HAART and its principal determinants in a cohort of Senegalese adults
BackgroundAccess to programmes providing highly active antiretroviral therapy (HAART) is recent in Africa. In Senegal, a national initiative was launched in 1998. The capacity of African patients toExpand
  • 206
  • 19
Counseling and choosing between infant-feeding options: overall limits and local interpretations by health care providers and women living with HIV in resource-poor countries (Burkina Faso, Cambodia,
As part of prevention of HIV mother-to-child transmission (PMTCT) strategies, HIV-positive women are asked to choose between two options regarding infant feeding: replacement feeding or exclusiveExpand
  • 81
  • 4
Revisiting Long-Term Adherence to Highly Active Antiretroviral Therapy in Senegal Using Latent Class Analysis
Background:Adherence is one of the main predictors of antiretroviral treatment success. A governmental initiative was launched in 1998 for HIV-infected patients in Senegal to provide access to highlyExpand
  • 45
  • 4
Accepted monitoring or endured quarantine? Ebola contacts' perceptions in Senegal.
During the 2014-2016 West Africa Ebola epidemic, transmission chains were controlled through contact tracing, i.e., identification and follow-up of people exposed to Ebola cases. WHO recommendationsExpand
  • 32
  • 4
Barriers to better care for people with AIDS in developing countries
WHO's “3 by 5” initiative to increase access to antiretroviral drugs to people with AIDS in developing countries is highly ambitious. Some of the biggest obstacles relate to delivering care
  • 50
  • 3
A 84-month follow up of adherence to HAART in a cohort of adult Senegalese patients.
OBJECTIVES To assess long-term adherence of the first HIV-1 patients receiving highly active antiretroviral therapy (HAART) in Senegal, and to identify the main determinants of adherence. METHODSExpand
  • 53
  • 3
Access to antiretroviral drugs and AIDS management in Senegal
ObjectivesDescription and analysis of the Senegalese Antiretroviral Drug Access Initiative (ISAARV), the first governmental highly active antiretroviral therapy (HAART) treatment programme in Africa,Expand
  • 61
  • 2
The Senegalese Antiretroviral Drug Access Initiative. An economic social behavioural and biomedical analysis.
This work presents an analysis of the preliminary results of the Senegalese Antiretroviral Drug Access Initiative (ISAARV) and of its evolution over its first three years. A general introduction toExpand
  • 25
  • 2
L'observance des traitements antirétroviraux et ses déterminants : analyse quantitative
Les capacités d'observance des patients aux traitements antirétroviraux dans les contextes sanitaires et sociaux africains sont encore peu documentées, en dépit de la mise en place des premiersExpand
  • 7
  • 2